DE69712124D1 - Hormones de croissance humaines mutantes et leur utilisation - Google Patents

Hormones de croissance humaines mutantes et leur utilisation

Info

Publication number
DE69712124D1
DE69712124D1 DE69712124T DE69712124T DE69712124D1 DE 69712124 D1 DE69712124 D1 DE 69712124D1 DE 69712124 T DE69712124 T DE 69712124T DE 69712124 T DE69712124 T DE 69712124T DE 69712124 D1 DE69712124 D1 DE 69712124D1
Authority
DE
Germany
Prior art keywords
growth hormone
mutantes
humaines
croissance
hormones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69712124T
Other languages
English (en)
Other versions
DE69712124T2 (de
Inventor
Kazuo Chihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JCR Pharmaceuticals Co Ltd
Original Assignee
JCR Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26391431&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69712124(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by JCR Pharmaceuticals Co Ltd filed Critical JCR Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of DE69712124D1 publication Critical patent/DE69712124D1/de
Publication of DE69712124T2 publication Critical patent/DE69712124T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
DE69712124T 1996-02-13 1997-02-12 Hormones de croissance humaines mutantes et leur utilisation Expired - Fee Related DE69712124T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5094096 1996-02-13
JP17864396 1996-06-18

Publications (2)

Publication Number Publication Date
DE69712124D1 true DE69712124D1 (de) 2002-05-29
DE69712124T2 DE69712124T2 (de) 2002-12-12

Family

ID=26391431

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69712124T Expired - Fee Related DE69712124T2 (de) 1996-02-13 1997-02-12 Hormones de croissance humaines mutantes et leur utilisation

Country Status (8)

Country Link
US (1) US6238915B1 (de)
EP (1) EP0790305B1 (de)
KR (1) KR980002066A (de)
AT (1) ATE216723T1 (de)
AU (1) AU723494B2 (de)
BR (1) BR9700957A (de)
CA (1) CA2197408A1 (de)
DE (1) DE69712124T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929151T2 (de) 1988-10-28 2000-07-20 Genentech Inc Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
US6780613B1 (en) 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
ATE196548T1 (de) 1991-05-10 2000-10-15 Genentech Inc Auswählen von agonisten und antagonisten von liganden
US6506595B2 (en) * 1998-03-31 2003-01-14 Itoham Foods Inc. DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
AU5649901A (en) * 2000-05-12 2001-11-20 Univ Wales Medicine Method for detecting growth hormone variations in humans, the variations and their uses
GB0011459D0 (en) * 2000-05-12 2000-06-28 Univ Wales Medicine Sequences
AU2002360349A1 (en) * 2001-11-09 2003-05-26 Pharmacia And Upjohn Company Single nucleotide polymorphisms in gh-1
GB0127213D0 (en) * 2001-11-12 2002-01-02 Univ Wales Medicine Method of detecting growth hormone variations in humans the variations and their uses
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
CA2498319A1 (en) * 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
GB0229725D0 (en) * 2002-12-19 2003-01-29 Univ Wales Medicine Haplotype partitioning and growth hormone SNPs
NZ525314A (en) * 2002-12-19 2005-02-25 Univ Cardiff Method and kit for diagnosing growth hormone dysfunction by determining SNP haplotypes of the proximal promoter region of the gene GH1
SE0300959D0 (sv) * 2002-12-19 2003-04-02 Pharmacia Ab Methods for predicting therapeutic response to agents acting on the growth hormone receptor
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP2446898A1 (de) 2010-09-30 2012-05-02 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Wachstumshormonen zur Verbesserung der Immunantwort bei immunsupprimierten Patienten
US11524986B2 (en) 2018-07-11 2022-12-13 Ohio University Peptide-based inhibitors of growth hormone action and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG49718A3 (en) 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
US5534617A (en) * 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
DE68929151T2 (de) * 1988-10-28 2000-07-20 Genentech Inc Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
WO1992019736A1 (en) 1991-05-01 1992-11-12 Ohio University Growth hormone antagonists

Also Published As

Publication number Publication date
DE69712124T2 (de) 2002-12-12
CA2197408A1 (en) 1997-08-14
AU723494B2 (en) 2000-08-31
BR9700957A (pt) 1998-12-08
KR980002066A (ko) 1998-03-30
EP0790305B1 (de) 2002-04-24
US6238915B1 (en) 2001-05-29
ATE216723T1 (de) 2002-05-15
AU1266497A (en) 1997-08-21
EP0790305A1 (de) 1997-08-20

Similar Documents

Publication Publication Date Title
DE69712124D1 (de) Hormones de croissance humaines mutantes et leur utilisation
DE59811840D1 (de) Zusammensetzung zur therapie von diabetes mellitus und fettsucht
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
DE69101217D1 (de) Ski mit laufflächenteil, ober Körper und Support für Bindungen.
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
EP0825996A4 (de) Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
AU3062384A (en) Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
WO2000066730A3 (en) Laminin 2 and methods for its use
HUP9902640A2 (hu) Gliasejtvonal-eredetű neurotróf faktor receptor
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
DE3853446D1 (de) Fibronectinbindungsprotein und dessen Herstellung.
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
DE237398T1 (de) Verfahren zur herstellung biologisch aktiver polypeptide, so erhaltene polypeptide und diese enthaltende zusammensetzungen.
PE20399A1 (es) Muteina ob
DK0977859T3 (da) Den neurotrofiske faktor NNT-1
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
EP0832109A4 (de) Faktor-2, homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung
WO2001029084A3 (en) Novel human proteins and polynucleotides encoding the same
DE3869939D1 (de) Biologisch wirksame peptide.
WO2001068693A8 (fr) Nouveau polypeptide, proteine humaine de reception cannabinoide 7, et polynucleotide codant pour ce polypeptide
ATE104344T1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee